5601-23-0Relevant articles and documents
KOtBu-Catalyzed Michael Addition Reactions Under Mild and Solvent-Free Conditions
Thiyagarajan, Subramanian,Krishnakumar, Varadhan,Gunanathan, Chidambaram
supporting information, p. 518 - 523 (2020/02/04)
Designed transition metal complexes predominantly catalyze Michael addition reactions. Inorganic and organic base-catalyzed Michael addition reactions have been reported. However, known base-catalyzed reactions suffer from the requirement of solvents, additives, high pressure and also side-reactions. Herein, we demonstrate a mild and environmentally friendly strategy of readily available KOtBu-catalyzed Michael addition reactions. This simple inorganic base efficiently catalyzes the Michael addition of underexplored acrylonitriles, esters and amides with (oxa-, aza-, and thia-) heteroatom nucleophiles. This catalytic process proceeds under solvent-free conditions and at room temperature. Notably, this protocol offers an easy operational procedure, broad substrate scope with excellent selectivity, reaction scalability and excellent TON (>9900). Preliminary mechanistic studies revealed that the reaction follows an ionic mechanism. Formal synthesis of promazine is demonstrated using this catalytic protocol.
Visible light promoted thiol-ene reactions using titanium dioxide
Bhat, Venugopal T.,Duspara, Petar A.,Seo, Sangwon,Abu Bakar, Nor Syazwani Binti,Greaney, Michael F.
supporting information, p. 4383 - 4385 (2015/03/18)
The radical addition of thiols to alkenes is reported under photoredox conditions, using visible light and TiO2 as a cheap and readily available photocatalyst.
PHARMACEUTICAL USE OF 3-BENZYLSULFONYLPROPIONITRILE
-
Paragraph 9, (2015/04/22)
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 3-benzylsulfonylpropionitrile, or a pharmaceutically acceptable salt thereof. The present invention is directed to a method for treating